Eli Lilly and Company
Stock Forecast, Prediction & Price Target
Eli Lilly and Company Financial Estimates
Eli Lilly and Company Revenue Estimates
Eli Lilly and Company EBITDA Estimates
Eli Lilly and Company Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| CHF28.31B N/A | CHF28.54B 0.78% | CHF34.12B 19.56% | Avg: CHF52.68B Low: CHF52.68B High: CHF52.68B avg. 54.37% | Avg: CHF62.25B Low: CHF62.25B High: CHF62.25B avg. 18.17% | Avg: CHF61.88B Low: CHF61.88B High: CHF61.88B avg. -0.58% | Avg: CHF71.61B Low: CHF71.61B High: CHF71.61B avg. 15.71% |
Net Income
% change YoY
| CHF5.58B N/A | CHF6.24B 11.87% | CHF5.24B -16.08% | Avg: CHF16.63B Low: CHF15.84B High: CHF19.05B avg. 217.36% | Avg: CHF21.43B Low: CHF18.59B High: CHF26.18B avg. 28.89% | Avg: CHF24.64B Low: CHF24.64B High: CHF24.64B avg. 14.95% | Avg: CHF30.16B Low: CHF30.16B High: CHF30.16B avg. 22.41% |
EBITDA
% change YoY
| CHF8.73B N/A | CHF9.43B 7.94% | CHF8.56B -9.17% | Avg: CHF16.97B Low: CHF16.97B High: CHF16.97B avg. 98.16% | Avg: CHF20.06B Low: CHF20.06B High: CHF20.06B avg. 18.17% | Avg: CHF19.94B Low: CHF19.94B High: CHF19.94B avg. -0.58% | Avg: CHF23.07B Low: CHF23.07B High: CHF23.07B avg. 15.71% |
EPS
% change YoY
| $5.85 N/A | $6.57 12.30% | $5.8 -11.71% | Avg: $18.68 Low: $16.69 High: $20.07 avg. 222.05% | Avg: $24 Low: $19.59 High: $27.58 avg. 28.48% | Avg: $25.96 Low: $25.96 High: $25.96 avg. 8.15% | Avg: $31.78 Low: $31.78 High: $31.78 avg. 22.41% |
Operating Expenses
% change YoY
| CHF13.45B N/A | CHF13.63B 1.29% | CHF20.05B 47.12% | Avg: CHF12.47B Low: CHF12.47B High: CHF12.47B avg. -37.79% | Avg: CHF14.74B Low: CHF14.74B High: CHF14.74B avg. 18.17% | Avg: CHF14.65B Low: CHF14.65B High: CHF14.65B avg. -0.58% | Avg: CHF16.95B Low: CHF16.95B High: CHF16.95B avg. 15.71% |
FAQ
What is Eli Lilly and Company stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 70.90% in 2025-2028.
We have gathered data from 13 analysts. Their low estimate is 15.84B, average is 16.63B and high is 19.05B.
What is Eli Lilly and Company stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 21.91% in 2025-2028.
We have gathered data from 27 analysts. Their low revenue estimate is CHF52.68B, average is CHF52.68B and high is CHF52.68B.
What is Eli Lilly and Company stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 70.27% in 2025-2028.
We have gathered data from 13 analysts. Their low earnings per share estimate is $16.69, average is $18.68 and high is CHF20.07.